Discontinuation report FLAREX
| Report ID | 235987 |
| Drug Identification Number | 00756784 |
| Brand name | FLAREX |
| Common or Proper name | FLAREX 0.1%SUSP 5ML |
| Company Name | NOVARTIS PHARMACEUTICALS CANADA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | FLUOROMETHOLONE ACETATE |
| Strength(s) | 0.1% |
| Dosage form(s) | SUSPENSION |
| Route of administration | OPHTHALMIC OPHTHALMIC |
| Packaging size | 5ML |
| ATC code | S01BA |
| ATC description | ANTIINFLAMMATORY AGENTS |
| Reason for discontinuation | Business reasons |
| Anticipated discontinuation date | 2024-09-16 |
| Actual discontinuation date | |
| Remaining supply date | |
| Discontinuation status | To be discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | Exp. 03.2025 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 700 RUE SAINT-HUBERT MONTREAL, QUEBEC CANADA H2Y 0C1 |
| Company contact information | customer.relations@novartis.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2024-08-27 | French | Compare |
| v1 | 2024-08-27 | English | Compare |
Showing 1 to 2 of 2